Skip to main content

EU MDR Labeling – Are You Prepared?

New assessors coupled with changing rules and a shortage of resources can lead to ambiguity and result in potential product issues or a stop in manufacturing. Make sure your company understands the labeling requirements in the EU MDR specified in nine articles and two annexes.

Need help with your company’s MDR labeling process?

Definitions to Know

Label

Written, printed or graphic information appearing either on the device itself, or on the packaging of each unit or on the packaging of multiple devices.

Instructions for Use

The information provided by the manufacturer to inform the user of a device’s intended purpose and proper use and of any precautions to be taken, for example: websites, GUDID, EUDAMED, marketing materials.

Labeling

Published information regarding the identification, use, specifications, manufacture or limitations of a medical device.

Did you know? The word information appears 362 times in the regulation, more than any other word including risk.

Prohibited Acts (Article 7)

Ensure you do not mislead the user or the patient about the device’s intended purpose, safety and performance by:

  • Attributing functions and properties to the device which the device does not have.
  • Failing to inform the user or the patient of a likely risk.

Economic Operators (Articles 13, 16)

  • Indicate company name and the address. Do not obscure the label provided by the manufacturer.
  • If a distributor or importer modifies a device, be sure to indicate the activity carried out together with its name, trade name or trademark and the address of the distributor or importer.

Labeling / IFU Accompanying the Device (Articles 18, 21)

You need to provide instructions for use (IFU) along with your device. The IFU should include:

  • Cleaning and disinfection procedures.
  • Packaging and validated method of re-sterilization.
  • Information on appropriate processes for reuse.
  • Maximum number of reuses.
  • Signs of material degradation.
  • Procedures for safe disposal of devices after use.
    • For devices intended for use by lay persons, note the circumstances in which the user should consult a health care professional.

Content of the Device Labels (Articles 20, 22, 27)

On your label you will need to indicate:

  • If the device contains or incorporates a medicinal substance, a human blood or plasma derivative, or tissues or cells.
  • Hazardous substance information.
  • If the device is sterile, indication of its sterile state and the sterilization method.

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF

  • NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation

    May 20, 2026
    NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
    Read the Story
  • NSF Annual Review and Impact Report 2025 Now Live

    April 20, 2026
    NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
    Read the Story
  • Visit NSF at Making Pharma 2026

    April 10, 2026
    Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.
    Read the Story
  • Sign up to our Food and Wellness Newsletter

    March 31, 2026
    Stay informed with our bi-monthly newsletter, providing updates on emerging trends, industry developments, and key insights from across the food and nutrition industry. Subscribe today to stay ahead.
    Read the Story